Inventor · Danvers, MA, US

Shawn Hillier

13Patents
6h-index
13Co-inventors
59Inventor score

Filing activity: Dec 4, 2009 → Jul 29, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8211401B2 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA Chemistry; Metallurgy 66 Active
US8962799B2 Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereof Chemistry; Metallurgy 54 Active
US8211402B2 CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer Chemistry; Metallurgy 42 Active
US8840865B2 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof Chemistry; Metallurgy 29 Active
US8562945B2 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof Chemistry; Metallurgy 28 Active
US9956305B2 Organ protection in PSMA-targeted radionuclide therapy of prostate cancer Human Necessities 7 Active
US9120837B2 Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX Chemistry; Metallurgy 5 Active
US9433594B2 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof Chemistry; Metallurgy 5 Active
US11110108B2 Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors Chemistry; Metallurgy 1 Active
US9422251B2 Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX Chemistry; Metallurgy 0 Active
US10668174B2 Organ protection in PSMA-targeted radionuclide therapy of prostate cancer Human Necessities 0 Active
US11980633B2 Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors Chemistry; Metallurgy 0 Active
US11167049B2 Organ protection in PSMA-targeted radionuclide therapy of prostate cancer Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.